The Nation - News from April 7, 1986
- Share via
A drug that shortens the course of herpes infections and apparently lengthens the time between eruptions of herpes-related sores may be a breakthrough in treatment of the incurable disorder, a doctor reported. Details of two studies, appearing in the British journal Lancet, show that when intervir-A--not yet approved by the Food and Drug Administration--was applied to herpes sores, the eruptions quickly disappeared, and incidents of recurrent outbreaks were greatly reduced.
Sign up for Essential California
The most important California stories and recommendations in your inbox every morning.
You may occasionally receive promotional content from the Los Angeles Times.
